| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 217,976 | 199,628 | 176,672 | 191,044 | | Cost of Revenue | (219,687) | 219,687 |
-
| 155,286 | | | Gross Profit | 437,663 | (20,059) | 176,672 | 35,758 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 385,316 | (61,519) | 142,533 | 18,297 | | Non Recurring |
-
|
-
|
-
| 7,222 | | Others | 3,503 | 3,444 | 3,312 | 3,481 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,844 | 38,016 | 30,827 | 6,758 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,316 | 2,161 | (3,092) | (295) | | Earnings Before Interest And Taxes | 51,160 | 40,177 | 27,735 | 6,463 | | Interest Expense | 3,153 | 3,150 | 3,149 | 3,143 | | Income Before Tax | 48,007 | 37,027 | 24,586 | 3,320 | | Income Tax Expense | 14,594 | 13,653 | 9,120 | 4,050 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,413 | 23,374 | 15,466 | (730) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,413 | 23,374 | 15,466 | (730) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,413 | $23,374 | $15,466 | ($730) |
|
0.31% Nasdaq 
0.05%
Income Statement
